Onset features and time to diagnosis in Friedreich’s Ataxia

Archive ouverte

Indelicato, Elisabetta | Nachbauer, Wolfgang | Eigentler, Andreas | Amprosi, Matthias | Matteucci Gothe, Raffaella | Giunti, Paola | Mariotti, Caterina | Arpa, Javier | Durr, Alexandra | Klopstock, Thomas | Schöls, Ludger | Giordano, Ilaria | Bürk, Katrin | Pandolfo, Massimo | Didszdun, Claire | Schulz, Jörg, B | Boesch, Sylvia

Edité par CCSD ; BioMed Central -

International audience. Background: In rare disorders diagnosis may be delayed due to limited awareness and unspecific presenting symptoms. Herein, we address the issue of diagnostic delay in Friedreich's Ataxia (FRDA), a genetic disorder usually caused by homozygous GAA-repeat expansions. Methods: Six hundred eleven genetically confirmed FRDA patients were recruited within a multicentric natural history study conducted by the EFACTS (European FRDA Consortium for Translational Studies, ClinicalTrials.gov-Identifier NCT02069509). Age at first symptoms as well as age at first suspicion of FRDA by a physician were collected retrospectively at the baseline visit. Results: In 554 of cases (90.7%), disease presented with gait or coordination disturbances. In the others (n = 57, 9.3%), non-neurological features such as scoliosis or cardiomyopathy predated ataxia. Before the discovery of the causal mutation in 1996, median time to diagnosis was 4(IQR = 2-9) years and it improved significantly after the introduction of genetic testing (2(IQR = 1-5) years, p < 0.001). Still, after 1996, time to diagnosis was longer in patients with a) non-neurological presentation (mean 6.7, 95%CI [5.5,7.9] vs 4.5, [4.2,5] years in those with neurological presentation, p = 0.001) as well as in b) patients with late-onset (3(IQR = 1-7) vs 2(IQR = 1-5) years compared to typical onset < 25 years of age, p = 0.03). Age at onset significantly correlated with the length of the shorter GAA repeat (GAA1) in case of neurological onset (r = − 0,6; p < 0,0001), but not in patients with non-neurological presentation (r = − 0,1; p = 0,4). Across 54 siblings' pairs, differences in age at onset did not correlate with differences in GAA-repeat length (r = − 0,14, p = 0,3). Conclusions: In the genetic era, presentation with non-neurological features or in the adulthood still leads to a significant diagnostic delay in FRDA. Well-known correlations between GAA1 repeat length and disease milestones are not valid in case of atypical presentations or positive family history.

Suggestions

Du même auteur

Longitudinal changes of SARA scale in Friedreich ataxia: Strong influence of baseline score and age at onset

Archive ouverte | Porcu, Luca | CCSD

International audience. Abstract Background The Scale for Assessment and Rating of Ataxia (SARA) is widely used in different types of ataxias and has been chosen as the primary outcome measure in the European natura...

NfL and pNfH are increased in Friedreich’s ataxia

Archive ouverte | Hayer, Stefanie Nicole | CCSD

International audience. Abstract Objective To assess neurofilaments as neurodegenerative biomarkers in serum of patients with Friedreich’s ataxia. Methods Single molecule array measurements of neurofilament light (N...

Prediction of the disease course in Friedreich ataxia

Archive ouverte | Hohenfeld, Christian | CCSD

International audience. We explored whether disease severity of Friedreich ataxia can be predicted using data from clinical examinations. From the database of the European Friedreich Ataxia Consortium for Translatio...

Chargement des enrichissements...